FIGURE 2.
Overall (A) and PS-matched survival (B): HVAD patients had a significantly lower 5 years survival than HM3 patients in both unmatched and matched populations.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.